309 related articles for article (PubMed ID: 36972391)
1. What will it take to cure hepatitis B?
Jeng WJ; Lok ASF
Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972391
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy.
Zhao Q; Liu H; Tang L; Wang F; Tolufashe G; Chang J; Guo JT
Antiviral Res; 2024 Jan; 221():105782. PubMed ID: 38110058
[TBL] [Abstract][Full Text] [Related]
3. How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?
Wong GLH; Gane E; Lok ASF
J Hepatol; 2022 Jun; 76(6):1249-1262. PubMed ID: 35589248
[TBL] [Abstract][Full Text] [Related]
4. Can we cure hepatitis B virus with novel direct-acting antivirals?
Martinez MG; Villeret F; Testoni B; Zoulim F
Liver Int; 2020 Feb; 40 Suppl 1():27-34. PubMed ID: 32077597
[TBL] [Abstract][Full Text] [Related]
5. Toward a Functional Cure for Hepatitis B.
Lok ASF
Gut Liver; 2024 Mar; ():. PubMed ID: 38533651
[TBL] [Abstract][Full Text] [Related]
6. Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients.
García-López M; Lens S; Pallett LJ; Testoni B; Rodríguez-Tajes S; Mariño Z; Bartres C; García-Pras E; Leonel T; Perpiñán E; Lozano JJ; Rodríguez-Frías F; Koutsoudakis G; Zoulim F; Maini MK; Forns X; Pérez-Del-Pulgar S
J Hepatol; 2021 May; 74(5):1064-1074. PubMed ID: 33278456
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes.
Lin N; Ye A; Lin J; Liu C; Huang J; Fu Y; Wu S; Xu S; Wang L; Ou Q
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31723011
[TBL] [Abstract][Full Text] [Related]
8. APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients.
Kao JH; Jeng WJ; Ning Q; Su TH; Tseng TC; Ueno Y; Yuen MF
Hepatol Int; 2021 Aug; 15(4):833-851. PubMed ID: 34297329
[TBL] [Abstract][Full Text] [Related]
9. Latest developments in the treatment of hepatitis B.
Dandri M; Petersen J
Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
[TBL] [Abstract][Full Text] [Related]
10. Toward a Cure for Hepatitis B Virus Infection: Combination Therapy Involving Viral Suppression and Immune Modulation and Long-term Outcome.
Wu D; Ning Q
J Infect Dis; 2017 Nov; 216(suppl_8):S771-S777. PubMed ID: 29156046
[TBL] [Abstract][Full Text] [Related]
11. Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure.
Chang ML; Liaw YF
Drugs; 2023 Apr; 83(5):367-388. PubMed ID: 36906663
[TBL] [Abstract][Full Text] [Related]
12. Toward a new era of hepatitis B virus therapeutics: The pursuit of a functional cure.
Tsounis EP; Tourkochristou E; Mouzaki A; Triantos C
World J Gastroenterol; 2021 Jun; 27(21):2727-2757. PubMed ID: 34135551
[TBL] [Abstract][Full Text] [Related]
13. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
Gao Y; Li Y; Meng Q; Zhang Z; Zhao P; Shang Q; Li Y; Su M; Li T; Liu X; Zhuang H
J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369
[TBL] [Abstract][Full Text] [Related]
14. Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma.
Wu JW; Kao JH; Tseng TC
Clin Mol Hepatol; 2021 Oct; 27(4):524-534. PubMed ID: 33618507
[TBL] [Abstract][Full Text] [Related]
15. Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy.
Bazinet M; Anderson M; Pântea V; Placinta G; Moscalu I; Cebotarescu V; Cojuhari L; Jimbei P; Iarovoi L; Smesnoi V; Musteata T; Jucov A; Dittmer U; Gersch J; Holzmayer V; Kuhns M; Cloherty G; Vaillant A
Hepatol Commun; 2021 Nov; 5(11):1873-1887. PubMed ID: 34558823
[TBL] [Abstract][Full Text] [Related]
16. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.
Wong DK; Seto WK; Fung J; Ip P; Huang FY; Lai CL; Yuen MF
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1004-10.e1. PubMed ID: 23376799
[TBL] [Abstract][Full Text] [Related]
17. A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments.
Laupèze B; Vassilev V; Badur S
Expert Rev Gastroenterol Hepatol; 2023; 17(11):1135-1147. PubMed ID: 37847193
[TBL] [Abstract][Full Text] [Related]
18. Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy.
Wu L; Yang Z; Zheng M
J Viral Hepat; 2024 May; 31(5):255-265. PubMed ID: 38332479
[TBL] [Abstract][Full Text] [Related]
19. Review article: novel therapies for hepatitis B virus cure - advances and perspectives.
Lin CL; Kao JH
Aliment Pharmacol Ther; 2016 Aug; 44(3):213-22. PubMed ID: 27302653
[TBL] [Abstract][Full Text] [Related]
20. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?
Alonso S; Guerra AR; Carreira L; Ferrer JÁ; Gutiérrez ML; Fernandez-Rodriguez CM
BMC Gastroenterol; 2017 Dec; 17(1):168. PubMed ID: 29268704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
